Clinical Trial Update: Tiotropium + Procaterol vs Tiotropium + Placebo in COPD Patients [Phase 4]

View source ↗

Summary

Phase 4 trial comparing tiotropium with procaterol vs tiotropium with placebo in chronic obstructive pulmonary disease has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Procaterol (procaterol)
• tiotropium (tiotropium)

Snippet

Sponsor: Otsuka Pharmaceutical, Inc., Philippines | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 4 | Status: TERMINATED